Identification of Purine Inhibitors of Phosphodiesterase 7 (PDE7)
Overview
Authors
Affiliations
A series of purine based inhibitors of PDE7 has been derived from screening lead 1a. The synthesis, structure-activity relationships (SAR), and selectivity against several other PDE family members are described.
Kumar R, Khan M, Panwar A, Vashist B, Rai S, Kumar A Open Respir Med J. 2025; 18():e18743064340418.
PMID: 39839967 PMC: 11748061. DOI: 10.2174/0118743064340418241021095046.
Jibril T, Alzoubi K, Mhaidat N, Khabour O, Alqudah M, Rababah A Curr Res Pharmacol Drug Discov. 2024; 6:100182.
PMID: 38706525 PMC: 11067328. DOI: 10.1016/j.crphar.2024.100182.
Phosphodiesterase 7 Regulation in Cellular and Rodent Models of Parkinson's Disease.
Morales-Garcia J, Alonso-Gil S, Santos A, Perez-Castillo A Mol Neurobiol. 2019; 57(2):806-822.
PMID: 31473904 DOI: 10.1007/s12035-019-01745-z.
Redondo M, Palomo V, Brea J, Perez D, Martin-Alvarez R, Perez C ACS Chem Neurosci. 2012; 3(10):793-803.
PMID: 23077723 PMC: 3474265. DOI: 10.1021/cn300105c.
PDE5 Inhibitors as Potential Tools in the Treatment of Cystic Fibrosis.
Noel S, Dhooghe B, Leal T Front Pharmacol. 2012; 3:167.
PMID: 23024633 PMC: 3444771. DOI: 10.3389/fphar.2012.00167.